SXTC icon

China SXT Pharmaceuticals
SXTC

Overview Fund Activity

8 hedge funds and large institutions have $2.32M invested in China SXT Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$531K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$490K
3
UBS Group
3
UBS Group
Switzerland
$66K
4
HF
4
HRT Financial
New York
$44K
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$1.16M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$7K
Name Market Value Shares Shares
Change 		Shares
Change %
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$1.16M 2,200,766 +51,579 +2%
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$531K 1,007,546 +990,179 +5,701%
Renaissance Technologies
3
Renaissance Technologies
New York
$490K 929,408 +330,667 +55%
UBS Group
4
UBS Group
Switzerland
$66K 124,770 +104,770 +524%
HF
5
HRT Financial
New York
$44K 84,873 +84,873 New
BWA
6
Beam Wealth Advisors
Louisiana
$10K 17,000 – –
TSS
7
Two Sigma Securities
New York
$10K 19,419 +19,419 New
Citadel Advisors
8
Citadel Advisors
Florida
$7K 12,513 -11,799 -49%
CFGS
9
Concourse Financial Group Securities
Alabama
– – – –